115 related articles for article (PubMed ID: 28150908)
1. Lack of evidence for prognostic value of epidermal growth factor receptor intron-1 CA repeats for oral carcinomas.
Precht C; Blessmann M; Kluwe L; Scheld T; Schön G; Henningsen A; Pflug C; Smeets R; Heiland M; Gröbe A
Eur J Oral Sci; 2017 Apr; 125(2):95-101. PubMed ID: 28150908
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor intron-1 CA repeat polymorphism on protein expression and clinical outcome in Taiwanese oral squamous cell carcinoma.
Huang SF; Chien HT; Chuang WY; Lai CH; Cheng SD; Liao CT; Wang HM
Sci Rep; 2017 Jul; 7(1):4963. PubMed ID: 28694429
[TBL] [Abstract][Full Text] [Related]
3. EGFR intron-1 CA repeat polymorphism is a predictor of relapse and survival in complete resected only surgically treated esophageal cancer.
Vashist YK; Trump F; Gebauer F; Kutup A; Güngör C; Kalinin V; Muddasar R; Vettorazzi E; Yekebas EF; Brandt B; Pantel K; Izbicki JR
Target Oncol; 2014 Mar; 9(1):43-52. PubMed ID: 23377570
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor intron-1 polymorphism predicts gefitinib outcome in advanced non-small cell lung cancer.
Tiseo M; Capelletti M; De Palma G; Franciosi V; Cavazzoni A; Mozzoni P; Alfieri RR; Goldoni M; Galetti M; Bortesi B; Bozzetti C; Loprevite M; Boni L; Camisa R; Rindi G; Petronini PG; Ardizzoni A
J Thorac Oncol; 2008 Oct; 3(10):1104-11. PubMed ID: 18827605
[TBL] [Abstract][Full Text] [Related]
5. Exon 19 of EGFR mutation in relation to the CA-repeat polymorphism in intron 1.
Sueoka-Aragane N; Imai K; Komiya K; Sato A; Tomimasu R; Hisatomi T; Sakuragi T; Mitsuoka M; Hayashi S; Nakachi K; Sueoka E
Cancer Sci; 2008 Jun; 99(6):1180-7. PubMed ID: 18422739
[TBL] [Abstract][Full Text] [Related]
6. EGFR dinucleotide repeat polymorphism as a prognostic indicator in non-small cell lung cancer.
Dubey S; Stephenson P; Levy DE; Miller JA; Keller SM; Schiller JH; Johnson DH; Kolesar JM;
J Thorac Oncol; 2006 Jun; 1(5):406-12. PubMed ID: 17409891
[TBL] [Abstract][Full Text] [Related]
7. Intron 1 CA dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and gefitinib responsiveness in non-small-cell lung cancer.
Han SW; Jeon YK; Lee KH; Keam B; Hwang PG; Oh DY; Lee SH; Kim DW; Im SA; Chung DH; Heo DS; Bang YJ; Kim TY
Pharmacogenet Genomics; 2007 May; 17(5):313-9. PubMed ID: 17429313
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma.
Gröbe A; Eichhorn W; Fraederich M; Kluwe L; Vashist Y; Wikner J; Smeets R; Simon R; Sauter G; Heiland M; Blessmann M
J Oral Pathol Med; 2014 Mar; 43(3):205-10. PubMed ID: 24020871
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism in epidermal growth factor receptor intron 1 predicts prognosis of patients with esophageal cancer after chemoradiation and surgery.
Lee JM; Yang SY; Yang PW; Shun CT; Wu MT; Hsu CH; Lin CC; Cheng JC; Wang YH; Chuang TH; Chen JS; Hsu HH; Huang PM; Kuo SW; Lee YC
Ann Surg Oncol; 2011 Jul; 18(7):2066-73. PubMed ID: 21298351
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor intron 1 CA dinucleotide repeat polymorphism and survival of advanced gastric cancer patients treated with cetuximab plus modified FOLFOX6.
Han SW; Oh DY; Im SA; Park SR; Lee KW; Song HS; Lee NS; Lee KH; Choi IS; Lee MH; Kim MA; Kim WH; Bang YJ; Kim TY
Cancer Sci; 2010 Mar; 101(3):793-9. PubMed ID: 20047592
[TBL] [Abstract][Full Text] [Related]
11. [Correlation between epidermal growth factor receptor (EGFR) intron1 (CA) n microsatellite polymorphism, lymph node metastasis and expression of EGFR in non-small cell lung cancer].
Zhao L; Jiang X; Peng F; Zhou R
Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):476-7. PubMed ID: 21055178
[No Abstract] [Full Text] [Related]
12. Microsatellite GTn-repeat polymorphism in the promoter of heme oxygenase-1 gene is an independent predictor of tumor recurrence in male oral squamous cell carcinoma patients.
Vashist YK; Blessmann M; Trump F; Kalinin V; Kutup A; Schneider C; Gawad K; Kaifi JT; Schmelzle R; Izbicki JR; Yekebas EF
J Oral Pathol Med; 2008 Sep; 37(8):480-4. PubMed ID: 18312299
[TBL] [Abstract][Full Text] [Related]
13. No association between dinucleotide repeat polymorphism in intron 1 of the epidermal growth factor receptor gene EGFR and risk of lung cancer.
Lee SJ; Kim KM; Chae MH; Lee WK; Kam S; Cha SI; Han HS; Kim CH; Kang YM; Han SB; Park JY
Cancer Genet Cytogenet; 2007 Jan; 172(1):29-32. PubMed ID: 17175376
[TBL] [Abstract][Full Text] [Related]
14. Allelic length of a CA dinucleotide repeat in the egfr gene correlates with the frequency of amplifications of this sequence--first results of an inter-ethnic breast cancer study.
Buerger H; Packeisen J; Boecker A; Tidow N; Kersting C; Bielawski K; Isola J; Yatabe Y; Nakachi K; Boecker W; Brandt B
J Pathol; 2004 May; 203(1):545-50. PubMed ID: 15095477
[TBL] [Abstract][Full Text] [Related]
15. Inverse relationship between the length of the EGFR CA repeat polymorphism in lung carcinoma and protein expression of EGFR in the carcinoma.
Suzuki M; Kageyama S; Shinmura K; Okudela K; Bunai T; Nagura K; Igarashi H; Kiyose S; Mori H; Tao H; Goto M; Takamochi K; Mochizuki T; Suzuki K; Ohashi R; Ogawa H; Yamada T; Niwa H; Tsuneyoshi T; Sugimura H
J Surg Oncol; 2008 Nov; 98(6):457-61. PubMed ID: 18683191
[TBL] [Abstract][Full Text] [Related]
16. The status of EGFR CA SSR1 is a potential prognostic factor for patients with oral squamous cell carcinoma.
Lin YL; Wang WY; Lin JC; Wong YK; Chien YC
Oral Oncol; 2011 Jun; 47(6):482-6. PubMed ID: 21530363
[TBL] [Abstract][Full Text] [Related]
17. Shorter EGFR Dinucleotide Repeat Length Predicts Better Response of Patients with Advanced Non-small Cell Lung Cancer to EGFR Tyrosine Kinase Inhibitor.
Chen B; Luo J; Gu W; Shen L; Wang H; Zhou S
Cell Biochem Biophys; 2015 Dec; 73(3):799-804. PubMed ID: 27259328
[TBL] [Abstract][Full Text] [Related]
18. An epidermal growth factor receptor intron 1 polymorphism mediates response to epidermal growth factor receptor inhibitors.
Amador ML; Oppenheimer D; Perea S; Maitra A; Cusatis G; Iacobuzio-Donahue C; Baker SD; Ashfaq R; Takimoto C; Forastiere A; Hidalgo M
Cancer Res; 2004 Dec; 64(24):9139-43. PubMed ID: 15604284
[TBL] [Abstract][Full Text] [Related]
19. Relationship between epidermal growth factor receptor gene copy number and protein expression in oral cavity squamous cell carcinoma.
Huang SF; Cheng SD; Chien HT; Liao CT; Chen IH; Wang HM; Chuang WY; Wang CY; Hsieh LL
Oral Oncol; 2012 Jan; 48(1):67-72. PubMed ID: 21831696
[TBL] [Abstract][Full Text] [Related]
20. EGFR copy number alterations in primary tumors, metastatic lymph nodes, and recurrent and multiple primary tumors in oral cavity squamous cell carcinoma.
Huang SF; Chien HT; Cheng SD; Chuang WY; Liao CT; Wang HM
BMC Cancer; 2017 Aug; 17(1):592. PubMed ID: 28854970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
